HI
ABBV icon

Harper Investing’s AbbVie ABBV Stock Holding History

Harper Investing’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Buy
8,748
+1,829
+26% +$394K 0.74% 40
2026
Q1 		$1.5M Buy
6,919
+5,717
+476% +$1.27M 0.66% 37
2025
Q4 		$275K Buy
+1,202
New +$274K 0.12% 56

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Harper Investing's ABBV Position: Q2 2026 in Review

Harper Investing increased its AbbVie (ABBV) stake by 26% in Q2 2026, buying an estimated $394K and bringing the position to 8,748 shares worth $2.2M. The position accounts for 0.74% of the portfolio, ranked #40.

Harper Investing first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 1,734 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harper Investing held 8,748 shares of AbbVie worth $2.2M as of Q2 2026.
  • Harper Investing bought 1,829 AbbVie shares in Q2 2026, an estimated $394K.
  • AbbVie made up 0.74% of Harper Investing's portfolio in Q2 2026, its #40 holding.
  • Harper Investing first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 1,734 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harper Investing's 13F filing for Q2 2026, filed 22 Jul 2026.